NPCE vs XOM · rev $22.8M vs P/E 24, rev $201.16B
Neuropace Inc (NPCE) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
Latest reported NPCE revenue for 2026-06-30 was $22.8M. Net income was -$6.2M. Revenue was up 3.4% from 2026-03-31 to 2026-06-30. NPCE currently screens at market cap $312.2M.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
NPCE currently screens at market cap $312.2M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the NPCE and XOM stock pages for the full models.
Not investment advice.